Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance
Viruses · 22.08.2025 · 17 (9) · 1151
DOI: 10.3390/v17091151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 22.08.2025. Verfasst von Charles S Bodjo und 12 weiteren Autor:innen. Beteiligte Einrichtung: African Union-Pan African Veterinary Vaccine Centre (AU-PANVAC), Debre Zeit P.O. Box 1746, Ethiopia. Hauptthemen laut MEDLINE: Peste-des-Petits-Ruminants, Viral Vaccines, Peste-des-petits-ruminants virus, Thermotolerance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Internationale Zusammenarbeit, German Agency for International Cooperation (GIZ), African Union Commission.
Abstract (Originalsprache)
The Peste des Petits Ruminants (PPR) live attenuated vaccines, the PPR virus (PPRV) Nigeria 75/1 strain (lineage II) and PPRV India Sungry 96 strain (lineage IV), currently used for control and eradication programme are very efficient vaccines as they provide the host, sheep and goats, a lifelong immunity after a single minimum recommended dose of 102.5 TCID50/mL. Unfortunately, both live attenuated vaccines are thermolabile and their use requires maintaining the cold chain from the manufactory premises to the field as most PPR-infected regions are facing of hot climate, with poor infrastructure, and the maintenance of an effective cold chain remains a challenge. To address this challenge, efforts have focused on developing thermotolerant (ThT) PPR vaccines using different stabilisers and improving the freeze-drying process. This study aimed to define the criteria for the evaluation of the stability of ThT PPR vaccines. A total of 37 batches of freeze-dried PPR vaccines using the PPRV Nigeria 75/1 strain, including eight (8) and twenty-nine (29) vaccines labelled as ThT and conventional formulations, respectively, were tested to evaluate the stability at temperatures of 40 °C to simulate the field conditions in some hot climate regions. All the vaccine batches included in this study initially showed acceptable levels of residual moisture, below 3%, and titres above the minimum WOAH standard requirement of 102.5 TCID50/mL. Following the incubation at 40 °C, 56.7% and 46% of the 37 vaccine batches tested retained titres above 102.5 TCID50/mL on day 3 and day 5, respectively. These vaccines use stabilisers such as skimmed milk, lactalbumin–sucrose, trehalose and one unnamed product (which may be protected for patent). The mean of titre loss among the PPR vaccines maintaining titres above 102.5 TCID50/mL was 0.78 log10 at day 3 and 0.99 log10 at day 5, suggesting a significant early degradation during the first 3 days. Based on these data, it is proposed that thermotolerant PPR vaccines should maintain a minimum titre of 102.5 TCID50/mL for vaccine dose on day 5 post-incubation at 40 °C with a titre loss below 1 log10 per mL. Preliminary immunogenicity test results showed that the PPR ThT vaccine meeting this criterion could be used in the field without maintaining a cold chain for up to 3 weeks, offering a practical solution for vaccination in remote areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- African Union-Pan African Veterinary Vaccine Centre (AU-PANVAC), Debre Zeit P.O. Box 1746, Ethiopia.
- World Organisation for Animal Health (WOAH), Sub-Regional Representation for Eastern Africa, Nairobi P.O. Box 19687, Kenya.
- Food and Agriculture Organization of the United Nations (FAO), Viale delle Terme di Caracalla, 00153 Rome, Italy.
- Independent Researcher, Hahngasse 24-26/02 07, 1090 Vienna, Austria.
ORCID-Profile: Charles S Bodjo, Hassen Belay Gelaw, Zione D Luhanga, Jean-De-Dieu Baziki, Cisse R Moustapha Boukary, Simon Kihu, Satya Parida
Förderung
- Deutsche Gesellschaft für Internationale Zusammenarbeit
- German Agency for International Cooperation (GIZ)
- African Union Commission
Zitieren
APA
Bodjo, C. S., Gelaw, H. B., Luhanga, Z. D., Tessema, Y. D., Baziki, J. D., Boukary, C. R. M., Melesse, G. A., Chitsungo, E., Nwankpa, N., Kihu, S., Njeumi, F., Parida, S., & Diallo, A. (2025). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses, 17(9), 1151. https://doi.org/10.3390/v17091151
Vancouver
Bodjo CS, Gelaw HB, Luhanga ZD, Tessema YD, Baziki JD, Boukary CRM, et al. Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses. 2025;17(9):1151. doi:10.3390/v17091151
BibTeX
@article{Bodjo2025,
author = {Bodjo, Charles S and Gelaw, Hassen Belay and Luhanga, Zione D and Tessema, Yebechaye Degefa and Baziki, Jean-De-Dieu and Boukary, Cisse R Moustapha and Melesse, Gelagay Ayelet and Chitsungo, Ethel and Nwankpa, Nick and Kihu, Simon and Njeumi, Felix and Parida, Satya and Diallo, Adama},
title = {Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance},
journal = {Viruses},
year = {2025},
volume = {17},
number = {9},
pages = {1151},
doi = {10.3390/v17091151}
}
EUVIMED